Gonçalves Nuno, Monteiro Cristina, Calais Pereira Luísa, Mendes João Pedro, Couto José Paulo
General Surgery, Unidade Local de Saúde do Alto Minho, Viana do Castelo, PRT.
Cureus. 2025 Apr 22;17(4):e82801. doi: 10.7759/cureus.82801. eCollection 2025 Apr.
Gastric metastases from solid tumors are rare and often clinically silent. When present, they typically originate from primaries such as the lung, breast, or skin. Renal cell carcinoma (RCC), particularly the clear cell subtype, has a known metastatic potential, most commonly to the lungs, bones, and liver. Gastric involvement is extremely uncommon. We report a case of an 83-year-old man with a remote history of clear cell RCC treated with nephrectomy three decades earlier, who presented with melena, epigastric discomfort, and vomiting. Endoscopic evaluation revealed a conglomerate of friable, vegetative lesions in the stomach with signs of recent bleeding. Biopsies confirmed metastasis of clear cell RCC. Computed tomography (CT) imaging demonstrated multiple nodular intraluminal gastric lesions. Given the patient's advanced age, comorbidities, and known distant metastases, surgical treatment was deemed inappropriate. Palliative hemostatic radiotherapy was initiated for symptom control. This case highlights the potential for late gastric metastasis from clear cell RCC and emphasizes the importance of considering metastatic disease in the differential diagnosis of gastrointestinal bleeding, even decades after the initial oncologic treatment. Prompt endoscopic evaluation and histological confirmation are essential for diagnosis, while treatment decisions must be individualized based on disease burden and patient condition.
实体瘤的胃转移很少见,临床上通常无症状。一旦出现,它们通常起源于肺、乳腺或皮肤等原发性肿瘤。肾细胞癌(RCC),尤其是透明细胞亚型,具有已知的转移潜能,最常见转移至肺、骨和肝。胃受累极为罕见。我们报告一例83岁男性,30年前因透明细胞RCC行肾切除术,现出现黑便、上腹部不适和呕吐。内镜检查发现胃内有一堆易碎的、赘生性病变并有近期出血迹象。活检证实为透明细胞RCC转移。计算机断层扫描(CT)成像显示胃腔内有多个结节性病变。鉴于患者高龄、合并症及已知的远处转移,手术治疗被认为不合适。为控制症状开始了姑息性止血放疗。该病例突出了透明细胞RCC发生晚期胃转移的可能性,并强调在胃肠道出血的鉴别诊断中考虑转移性疾病的重要性,即使是在最初的肿瘤治疗数十年后。及时的内镜评估和组织学确认对诊断至关重要,而治疗决策必须根据疾病负担和患者情况个体化。